Home / Recalls / MPRX, Inc. dba Medical Park Pharmacy / D-0807-2020

D-0807-2020 Class II Terminated

Recalled by MPRX, Inc. dba Medical Park Pharmacy — Dallas, TX

Recall Details

Product Type
Drugs
Report Date
February 5, 2020
Initiation Date
December 18, 2019
Termination Date
December 13, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 bottles

Product Description

Liothyronine (T3) 80 mcg SR cap

Reason for Recall

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Distribution Pattern

TX

Code Information

Lot: 61253:42 Use by: 04/01/2020

Other recalls by MPRX, Inc. dba Medical Park Pharmacy

  • D-0816-2020 Class II — Squaric Acid 0.1% Topical Solution (Clinic) 30 mL (December 18, 2019)
  • D-0809-2020 Class II — Magic Bullet Supplement (December 18, 2019)
  • D-0818-2020 Class II — Tadalafil 20 mg Troche (December 18, 2019)
  • D-0819-2020 Class II — Tadalafil 6 mg Capsule (December 18, 2019)
  • D-0810-2020 Class II — Naltrexone 4.5 mg capsule (December 18, 2019)
  • D-0817-2020 Class II — T3/T4 SR 9 mcg/38 mcg capsule (December 18, 2019)
  • D-0813-2020 Class II — Progesterone E4M SR 100 mg capsules (December 18, 2019)
  • D-0815-2020 Class II — Sildenafil 80 mg capsules (December 18, 2019)
  • D-0811-2020 Class II — Progesterone 200 mg Troche (December 18, 2019)
  • D-0804-2020 Class II — Finasteride/Biotin 1 mg/50 mcg (December 18, 2019)